Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT in Lung Cancer
Open Access
- 6 January 2020
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 10 (1) , 26
Abstract
Although 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) is a sensitive nuclear medicine modality, specificity for characterizing lung cancer is limited. Tumor proliferation and early response to molecularly targeted therapy could be visualized using 3′-deoxy-3′[(18)F]-fluorothymidine (18F-FLT) PET/CT. The superiority of 18F-FLT PET/CT over 18F-FDG PET/CT in early therapeutic monitoring has been well described in patients after chemotherapy, radiotherapy, and/or chemo/radiotherapy. In thispilot study, we explorethe use of 18F-FLT PET/CT as an early response evaluation modality in patients with lung cancerand provide specific case studies of patients with small cell lung cancer and non-small cell lung cancer who received novel targeted therapies. Early response for c-MET inhibitor was observed in four weeks and for MDM2 inhibitor in nine days.Keywords
This publication has 26 references indexed in Scilit:
- FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot StudyFrontiers in Oncology, 2019
- Predictive value of positron emission tomography for the prognosis of molecularly targeted therapy in solid tumorsOncoTargets and Therapy, 2018
- Correlations of 18F-FDG and 18F-FLT uptake on PET with Ki-67 expression in patients with lung cancer: a meta-analysisActa Radiologica, 2017
- The role of new PET tracers for lung cancerLung Cancer, 2016
- A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patientsEuropean Journal of Cancer, 2016
- FLT PET-CT in evaluation of treatment responseIndian Journal of Nuclear Medicine, 2014
- Limits of [18F]-FLT PET as a Biomarker of Proliferation in OncologyPLOS ONE, 2013
- Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Designing a Pronucleotide Stratagem: Lessons from Amino Acid Phosphoramidates of Anticancer and Antiviral PyrimidinesMini-Reviews in Medicinal Chemistry, 2004
- Imaging proliferation in vivo with [F-18]FLT and positron emission tomographyNature Medicine, 1998